99- Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, et al. Comparison
of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department Of
Veterans Affairs Cooperative Study. Arthritis Rheum. 1996;39(12):2004–12. - Calin A, Nakache JP, Gueguen A, Zeidler H, Mielants H, Dougados M. Defi ning disease
activity in ankylosing spondylitis: is a combination of variables (bath ankylosing spondylitis
disease activity index) an appropriate instrument? Rheumatology (Oxford).
1999;38(9):878–82. - Creemers MC, Franssen MJ, van't Hof MA, Gribnau FW, van de Putte LB, van Riel
PL. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring sys-
tem. Ann Rheum Dis. 2005;64(1):127–9. - Calin A, Mackay K, Santos H, Brophy S. A new dimension to outcome: application of the
bath ankylosing spondylitis radiology index. J Rheumatol. 1999;26(4):988–92. - Whiting-O'Keefe QE, Stone JH, Hellmann DB. Validity of a vasculitis activity index for
systemic necrotizing vasculitis. Arthritis Rheum. 1999;42(11):2365–71. - Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al. Treating
rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum
Dis. 2010;69(4):631–7. - Boutry N, Hachulla E, Flipo RM, Cortet B, Cotten A. MR imaging fi ndings in hands in early
rheumatoid arthritis: comparison with those in systemic lupus erythematosus and primary
Sjögren syndrome. Radiology. 2005;236(2):593–600.
3 PROMs (MDHAQ/RAPID3) and Physician RheuMetric Measures